Literature DB >> 12387787

Total retinal nitric oxide production is increased in intraocular pressure-elevated rats.

Andrew W Siu1, Mason C P Leung, Chi H To, Flora K W Siu, J Z Ji, Kwok Fai So.   

Abstract

Nitric oxide (NO) is a well-known vaso-dilator but its regulation in the retina is unclear. This study was conducted to quantify total NO production and retinal ganglion cell (RGC) loss in an experimental glaucoma model. Three quarters of the peri-limbal/episcleral drainage vessels and anterior angle (right eyes) of Sprague-Dawley rats were thermally blocked using laser irradiation, while the left eyes served as controls. We measured the intraocular pressure (IOP) of both eyes using a digital tonometer (Tonopen) 21, 28 and 35 days after the laser treatment. After 35 days, we determined the total NO level in retinas and remaining ocular tissues for the laser-treated and control eyes using a spectro-photometric assay. The viable RGC numbers were also determined by counting the cell bodies stained retrogradely by fluoro-gold. The laser treatment significantly increased the IOP 2.0-2.6x throughout the whole periodof measurements (P<0.0001). The mean total RGC number decreased significantly from 98725+/-5383 (+/-S.E. (M.)) to 69276+/-5592, or 29.8% reduction, in the laser-treated eyes after 35 days (P=0.008). The mean total NO level in the laser-treated retina was significantly increased by 2.4x compared with controls (P=0.016), but no significant difference was found in the eyecups (P>0.05). Laser treatment resulted in significant IOP elevation and RGC loss, suggesting that thermal coagulation of the perilimbal region may provide an alternate protocol for glaucoma study. NO level was increased by two-fold in the retina but not in other ocular tissues. Since NO is capable of producing powerful peroxynitrite anions and hydroxyl radicals, elevated level of NO has a potential role in glaucoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387787

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  13 in total

1.  In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death.

Authors:  Yujing Bai; ZhiHua Shi; Yehong Zhuo; Jing Liu; Andrey Malakhov; Eunhwa Ko; Kevin Burgess; Henry Schaefer; Pedro F Esteban; Lino Tessarollo; H Uri Saragovi
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

2.  Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma.

Authors:  Sarah Taylor; Claudia J Calder; Julie Albon; Jonathan T Erichsen; Micheal E Boulton; James E Morgan
Journal:  Exp Eye Res       Date:  2011-02-04       Impact factor: 3.467

3.  Capillary electrophoretic assay for nitrate levels in the vitreous of proliferative diabetic retinopathy.

Authors:  Leyi Gao; Jose S Pulido; R Mark Hatfield; Robert F Dundervill; Colin A McCannel; Scott A Shippy
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-11-13       Impact factor: 3.205

4.  Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.

Authors:  John Danias; Fran Shen; Manolis Kavalarakis; Bin Chen; David Goldblum; Kevin Lee; Maria-Florencia Zamora; YanLing Su; Scott E Brodie; Steven M Podos; Thom Mittag
Journal:  Exp Eye Res       Date:  2005-08-16       Impact factor: 3.467

5.  Effects of melatonin on the nitric oxide treated retina.

Authors:  A W Siu; G G Ortiz; G Benitez-King; C H To; R J Reiter
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

6.  Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.

Authors:  ZhiHua Shi; Marcelo Rudzinski; Karen Meerovitch; Frédéric Lebrun-Julien; Elena Birman; Adriana Di Polo; H Uri Saragovi
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

7.  Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.

Authors:  Miin Roh; Yan Zhang; Yusuke Murakami; Aristomenis Thanos; Sung Chul Lee; Demetrios G Vavvas; Larry I Benowitz; Joan W Miller
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

8.  T-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucoma.

Authors:  ManSin Wong; Ping Huang; Weiyi Li; Ying Li; Samuel S Zhang; Chun Zhang
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

9.  Short-Term Moderately Elevated Intraocular Pressure Is Associated With Elevated Scotopic Electroretinogram Responses.

Authors:  Vivian Choh; Akshay Gurdita; Bingyao Tan; Ratna C Prasad; Kostadinka Bizheva; Karen M Joos
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

Review 10.  Current concepts in the pathophysiology of glaucoma.

Authors:  Renu Agarwal; Suresh K Gupta; Puneet Agarwal; Rohit Saxena; Shyam S Agrawal
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.